Point-of-Care Molecular Diagnostics Market Forecast: Technological Growth Map with an Impact-Analysis

1
Point-of-Care Molecular Diagnostics Market
Global Analysis and Forecast to 2028

• Published Date Oct 2021

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Point-of-Care Molecular Diagnostics Market
  Forecast to 2028 - COVID-19 Impact and Global
  Analysis By Product Services (Assays and Kits,
  Instruments, and Services and Software),
  Technology PCR, Isothermal Nucleic Acid
  Amplification Technology (INAAT), and Other
  Technologies, Application (Infectious Diseases,
  Oncology, Hematology, Prenatal Testing,
  Endocrinology, and Other Applications), and End
  User (Hospitals and Clinics, Diagnostic
  Laboratories, Research and Academic Institutes,
  and Others) Geography

3
Point-of-Care Molecular Diagnostics Market
Overview
Email sales_at_theinsightpartners.com

• The Point-of-Care Molecular Diagnostics Market is
  projected to reach US 5,381.18 million by 2028
  from US 2,230.94 million in 2021 it is expected
  to grow at a CAGR of 13.4 from 2021 to 2028.
• The growth of the market is attributed to the
  growing demand for specific viral detection
  methods that consume less time for timely
  infection control and rising incidence of
  infectious diseases. However, the pricing
  pressures owing to reimbursement cuts restrain
  the Point-of-Care Molecular Diagnostics market
  growth. Point-of-care molecular diagnostics
  comprises portable devices and assays kits to
  detect and diagnose diseases from human samples,
  such as throat swab, blood, serum, and stool.
  Molecular diagnostics are shifting from
  centralized laboratories to decentralized
  point-of-care molecular testing, due to its
  simplicity, convenience, rapid turnaround time,
  and potential to improve patient outcomes. Owing
  to these advantages, it can be applied for
  diagnosis in low-resource or remote areas.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment By Type-
• By Product Services (Assays and Kits,
  Instruments, and Services and Software)
• Technology PCR, Isothermal Nucleic Acid
  Amplification Technology (INAAT), and Other
  Technologies
• Application (Infectious Diseases, Oncology,
  Hematology, Prenatal Testing, Endocrinology, and
  Other Applications)
• End User (Hospitals and Clinics, Diagnostic
  Laboratories, Research and Academic Institutes,
  and Others)

Download Sample Here
5
Point-of-Care Molecular Diagnostics Market Value
Email sales_at_theinsightpartners.com

• CAGR of 13.4 (2021 - 2028)

6
Company Profiles
Email sales_at_theinsightpartners.com

• bioMérieux SA
• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• Enzo Biochem, Inc.
• Abbott
• binx health, Inc.
• Meridian BioScience, Inc.
• Biocartis
• Quidel Corporation
• Bio-Rad Laboratories, Inc.

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com